Summary
A panel of 17 monoclonal antibodies (MAbs) to the G1 and G2 envelope glycoproteins of Rift Valley fever (RVF) virus were used to analyze the topography and functional properties of the viral antigenic sites. Four heterogeneous antigenic regions which may be interlinked were identified on the G1 protein and four distinct domains on the G2 protein by competitive binding assays. Comparison of the biological activities and epitope specificities of the MAbs against G1 showed that the antigenic domains I, II, and IV were involved in virus neutralization and haemagglutination at different potencies. For both the G1 and G2 proteins, determinants mapping to domain G1 Ia and G2 Ia were associated with very strong neutralization independent of complement (C′), suggesting that they represent biologically important areas. Domain G2 II was involved in haemagglutination and weak C′ dependent neutralization while the other two G2 regions had no haemagglutination function and neutralized to a low level only in the presence of C'. Epitopes Ia and IIb on G1 and Ia and IIa on G2 were also associated with protection of mice against virulent RVFV infection, indicating that both envelope glycoproteins play an important role in RVF viral infection and pathogenesis.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Arikawa J, Schmaljohn AL, Dalrymple JM, Schmaljohn CS (1989) Characterization of Hantaan virus envelope glycoprotein antigenic determinants defined by monoclonal antibodies. J Gen Virol 70: 615–624
Battles JK, Dalrymple JM (1988) Genetic variation among geographic isolates of Rift valley fever virus. Am J Trop Med Hyg 39: 617–631
Besselaar TG, Blackburn NK (1988) Antigenic analysis of West Nile virus strains using monoclonal antibodies. Arch Virol 99: 75–88
Bishop DHL, Calisher CH, Casals J, Chumakov MP, Gaidamovich SY, Hannoun C, Lvov DK, Marshall ID, Oker-Blom NM, Petterson RF, Porterfield JS, Russell PK, Shope RE, Westaway EG (1980) Bunyaviridae. Intervirology 14: 125–143
Blackburn NK, Swanepoel R (1980) An investigation of flavivirus infections of cattle in Zimbabwe Rhodesia with particular reference to Wesselsbron virus. J Hyg (Camb) 85: 1–33
Boere WAM, Harmsen T, Vinjè J, Benaissa-Trouw BJ, Kraaijeveld C, Snippe H (1984) Identification of distinct antigenic determinants on Semliki Forest virus by using monoclonal antibodies with different antiviral activities. J Virol 52: 575–582
Boere WAM, Benaissa-Trouw BJ, Harmsen T, Erich T, Kraaijeveld CA, Snippe H (1985) Mechanisms of monoclonal antibody-mediated protection against virulent Semliki Forest virus. J Virol 54: 546–551
Clarke DH, Casals J (1958) Techniques for haemagglutination and haemagglutination inhibition with arthropod-borne viruses. Am J Trop Med Hyg 7: 561–573
Collett MS, Purchio AF, Keegan K, Frazier S, Hays W, Anderson DK, Parker MD, Schmaljohn C, Schmidt J, Dalrymple JM (1985) Complete nucleotide sequence of the M RNA segment of Rift Valley fever virus. Virology 144: 228–245
Collett MS, Keegan K, Hu SL, Sridhar P, Purchio AF, Ennis WH, Dalrymple JM (1987) Protective subunit immunogens to Rift Valley fever virus from bacteria and recombinant vaccinia virus. In: Mahy BWJ, Kolakofsky D (eds) The biology of negative strand viruses. Elsevier, Amsterdam, pp 321–329
Dalrymple JM, Hasty SE, Kakach LT, Collett MS (1989) Mapping protective determinants of Rift Valley fever virus using recombinant vaccinia viruses. In: Lerner RA, Ginsberg H, Chanock R, Brown F (eds) Vaccines '89. Cold Spring Harbor Laboratory, New York, pp 371–375
Heinz FX, Mandl C, Berger R, Tuma W, Kunz C (1984) Antibody-induced conformational changes result in enhanced avidity of antibodies to different antigenic sites on the tick-borne encephalitis virus glycoprotein. Virology 133: 25–34
Henning D, Nielsen K (1987) Peroxidase-labelled monoclonal antibodies for use in enzyme immunoassay. J Immunoassay 8: 297–307
Keegan K, Collett MS (1986) Use of bacterial expression cloning to define the amino acid sequences of antigenic determinants on the G2 glycoprotein of Rift Valley fever virus. J Virol 58: 263–270
Kingsford L (1984) Enhanced neutralization of La Crosse virus by the binding of specific pairs of monoclonal antibodies to the G1 glycoprotein. Virology 136: 265–273
Kingsford L, Ishizawa LD, Hill DW (1983) Biological activities of monoclonal antibodies reactive with antigenic sites mapped on the G1 glycoprotein of La Crosse virus. Virology 129: 443–455
Laughlin LW, Meegan JM, Strausbaugh LJ, Morens DM, Watten RH (1979) Epidemic Rift Valley fever in Egypt: observations of the spectrum of human illness. Trans Roy Soc Trop Med Hyg 73: 630–633
Lubeck MD, Gerhard W (1981) Topological mapping of antigenic sites on the influenza A/PR/8/34 virus haemagglutinin using monoclonal antibodies. Virology 113: 64–72
Lubeck MD, Gerhard W (1982) Conformational changes at topologically distinct antigenic sites on the influenza A/Pr/8/34 virus HA molecule are induced by the binding of monoclonal antibodies. Virology 118: 1–7
Lussenhop NO, Goertz R, Wakube-Bunoti M, Gehrz R, Kari B (1988) Epitope analysis of human cytomegalovirus glycoprotein complexes using murine monoclonal antibodies. Virology 164: 362–372
Meegan JM, Digoutte JP, Peters CJ, Shope RE (1983) Monoclonal antibodies to identify Zinga virus as Rift Valley fever virus. Lancet i: 641
Pifat DY, Osterling MC, Smith JF (1988) Antigenic analysis of Punta Toro virus and identification of protective determinants with monoclonal antibodies. Virology 167: 442–450
Rice RM, Erlick BJ, Rosato RR, Eddy GA, Mohanty SB (1980) Biochemical characterization of Rift Valley fever virus. Virology 105: 256–260
Robeson G, El Said LH, Brandt W, Dalrymple J, Bishop DHL (1979) Biochemical studies on the phlebotomus fever group viruses (Bunyaviridae family). J Virol 30: 339–350
Roehrig JT, Day JW, Kinney RM (1982) Antigenic analysis of the surface glycoproteins of a Venezuelen equine encephalomyelitis virus (TC-83) using monoclonal antibodies. Virology 118: 269–278
Roehrig JT (1986) The use of monoclonal antibodies in studies of the structural proteins of Togaviruses and Flaviviruses. In: Schlesinger S, Schlesinger MJ (eds) The Togaviridae and Flaviviridae. Plenum, New York, pp 265–272
Saluzzo JF, Smith JF (1990) Use of reassortment viruses to map attenuating and temperature-sensitive mutations of the Rift Valley fever virus MP-12 vaccine. Vaccine 8: 369–375
Schmaljohn AL, Johnson ED, Dalrymple JM, Cole GA (1982) Non-neutralizing monoclonal antibodies can prevent lethal alphavirus encephalitis. Nature 297: 70–72
Schmaljohn CS, Parker MD, Ennis WH, Dalrymple JM, Collett MS, Suzich JA, Schmaljohn AL (1989) Baculovirus expression of the M segment of Rift Valley fever virus and examination of antigenic and immunogenic properties of the expressed proteins. Virology 170: 184–192
Shope RE, Peters CJ, Davies FG (1982) The spread of Rift Valley fever and approaches to its control. Bull WHO 60: 299–304
Smith JF, Brown DT (1977) Envelopment of Sindbis virus: synthesis and organization of proteins in cells infected with wild type and maturation-defective mutants. J Virol 22: 662–678
Spiegelberg HL (1974) Biological activities of immunoglobulins of different classes and subclasses. In: Dixon FX, Kunkel HG (eds) Advances in immunology, vol 19. Academic Press, New York, pp 259–294
Stanley J, Cooper SJ, Griffin DE (1986) Monoclonal antibody cure and prophylaxis of lethal Sindbis virus encephalitis in mice. J Virol 58: 107–115
Stone MR, Nowinski RC (1980) Topological mapping of murine leukemia virus proteins by competition binding assays with monoclonal antibodies. Virology 100: 370–381
Swanepoel R, Struthers JK, Erasmus MJ, Shepherd SP, McGillivray GM (1986) Comparison of techniques for demonstrating antibodies to Rift Valley fever virus. J Hyg (Camb) 97: 317–329
Van Velden DJJ, Meyer JD, Olivier J, Gear JHS, McIntosh B (1977) Rift Valley fever affecting humans in South Africa. A clinico-pathological study. S A Med J 51: 867–871
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Besselaar, T.G., Blackburn, N.K. Topological mapping of antigenic sites on the Rift Valley fever virus envelope glycoproteins using monoclonal antibodies. Archives of Virology 121, 111–124 (1991). https://doi.org/10.1007/BF01316748
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01316748